Skip to content

uniQure QURE Net Investment in Lease

Net Investment in Lease at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
Precigen logo
PrecigenPGEN
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
PTC Therapeutics logo
PTC TherapeuticsPTCT

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's net investment in lease?
uniQure (QURE) reported net investment in lease of $12.26M in Q1 2026.
How has uniQure's net investment in lease changed year-over-year?
uniQure's net investment in lease decreased by 8.9% year-over-year, from $13.47M to $12.26M.
What is the long-term trend for uniQure's net investment in lease?
Over 5 years (2020 to 2025), uniQure's net investment in lease has grown at a -13.6% compound annual growth rate (CAGR), from $26.09M to $12.53M.